I've said all along that we're building Axovant as a…
“I've said all along that we're building Axovant as a lasting company for the long run, not to hand over that upside to a pharma company in the future.”
About This Quote
This interpretation was drafted with AI assistance. It is one reading of the quote, not the author's own explanation.
Building a lasting biotech firm means retaining upside rather than selling to larger pharma, preserving long‑term value.
In simple terms: Keep company ownership for future growth.
Key Takeaway
Focus on sustainable growth, not quick exits.
Themes
business
biotech
long‑term strategy
Mood
strategic
optimistic
Type
entrepreneurial
inspirational
When to use this quote
- startup fundraising
- strategic partnerships
- R&D investment
- exit planning
Key Concepts
Entrepreneurship
value creation
Questions to Reflect On
- Is long‑term vision realistic in fast‑moving biotech?
- What safeguards protect against premature exits?
A Different Perspective
Market pressures may push toward early sale.